21 hasil untuk "M Musso"
Menampilkan 1–20 · 0,93 detik · RSS
-
Artikel Jurnal
Effects of R-enantiomer (GR66234A) and L-enantiomer (GR66235A) of telupidine, a new dihydropyridine derivative, on cell lines displaying the multidrug resistant phenotype
BACKGROUND. Many dihydropyridine analogues with calcium channel blocker activity are able to reverse multidrug resistance (MDR). We studied the daunorubicin resistance reversing activity of the R enantiomer (GR66234A) and the L-enantiomer (GR66235 A) of teludipine, a new lipophilic calcium channel…
-
Artikel Jurnal
Synchrotron-based UV resonance Raman scattering for investigating ionic liquid-water solutions
This work shows that bulk ionic liquids (ILs) and their water solution can be conveniently investigated by synchrotron-based UV resonance Raman (UVRR) spectroscopy. The main advantages of this technique for the investigation of the local structure and intermolecular interactions in…
-
Artikel Jurnal
Improving CT Image Analysis of Augmented Bone with Raman Spectroscopy
In recent years, bone graft substitutes have been increasingly used in the medical field, for example, in order to promote new bone formation. Microcomputed tomography (μ-CT) is an image-guided technique used in medicine as well as in materials science, enabling the characterization of biomaterials…
-
Artikel Jurnal
P187 | SINGLE-CENTER REAL-LIFE EXPERIENCE IN MULTIPLE MYELOMA PATIENTS TREATED WITH CAR-T THERAPY (IDE-CEL)
Idecabtagene vicleucel is the first chimeric antigen receptor (CAR)-T approved in Italy for the treatment of relapsed and refractory three-class exposed multiple myeloma. This therapy is showing encouraging results in heavily pretreated patients, changing the therapeutic setting for advanced…
-
Artikel Jurnal
DP005 | REAL-WORLD PROSPECTIVE OBSERVATIONAL STUDY OF TAFASITAMAB WITH LENALIDOMIDE IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: PRELIMINARY RESULTS FROM THE ITALIAN PRO-MIND STUDY
Tafasitamab, a humanized anti-CD19 monoclonal antibody, has shown clinical efficacy in relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL) in clinical trials when combined with lenalidomide. Although some retrospective real-world studies have been reported on this combination…
-
Artikel Jurnal
The RNA-binding protein EIF4A3 promotes axon development by direct control of the cytoskeleton
Summary: The exon junction complex (EJC), nucleated by EIF4A3, is indispensable for mRNA fate and function throughout eukaryotes. We discover that EIF4A3 directly controls microtubules, independent of RNA, which is critical for neural wiring. While neuronal survival in the developing mouse cerebral…
-
Artikel Jurnal
Graphene-based quantum Hall arrays in cross–square recursion configurations
In electrical metrology, the quantum Hall effect is accessed at the Landau level filling factor ν = 2 plateau to define and disseminate the unit of electrical resistance (ohm). The robustness of the plateau is only exhibited at this Landau level filling factor and thus places a constraint on the…
-
Artikel Jurnal
Complexity of the 5′ Untranslated Region of EIF4A3, a Critical Factor for Craniofacial and Neural Development
Repeats in coding and non-coding regions have increasingly been associated with many human genetic disorders, such as Richieri-Costa-Pereira syndrome (RCPS). RCPS, mostly characterized by midline cleft mandible, Robin sequence and limb defects, is an autosomal-recessive acrofacial dysostosis mainly…
-
Artikel Jurnal
Conductivity space isotherm behavior in quantum anomalous Hall devices
The quantum Hall effect (QHE) has enhanced accessibility to measure and disseminate electrical units, owed in part to the recently redefined International System of Units in 2019. Graphene remains one of the preferred options to realize the ohm despite the limitations of high magnetic fields to…
-
Artikel Jurnal
C091 | PATIENTS WITH RELAPSED/REFRACTORY PMBCL HAVE BETTER SURVIVAL WHEN THE SALVAGE STRATEGY INCLUDES CAR T-CELLS: AN ANALYSIS OF THE REPRIME-FIL AND THE CART-SIE STUDIES
Introduction Salvage treatment of relapsed/refractory (R/R) primary mediastinal B-cell lymphoma (PMBCL) patients (pts) has been revolutionized by the use of Chimeric Antigen Receptor (CAR) T-cell therapy targeting CD19. This study aims to compare overall survival (OS) between R/R PMBCL pts treated…
-
Artikel Jurnal
P53 | NATIONWIDE EXPERIENCE WITH STANDARD OF CARE IDECABTAGENE VICLEUCEL IN RELAPSED/REFRACTORY MULTIPLE MYELOMA: A REAL WORLD STUDY ON BEHALF OF THE GRUPPO ITALIANO MALATTIE EMATOLOGICHE DELL'ADULTO FOUNDATION
The treatment landscape of relapsed refractory multiple myeloma (RRMM) has recently been enriched by the introduction of chimeric antigen receptor T-cells (CAR-T). Since their approval stemmed from controlled clinical trials, real-world validation on a national level in unselected cohorts of…
-
Artikel Jurnal
C013 | AN ITALIAN MULTICENTER RETROSPECTIVE OBSERVATIONAL STUDY TO ASSESS EFFECTIVENESS AND SAFETY OF ZANUBRUTINIB FOR PATIENTS WITH MARGINAL ZONE LYMPHOMA TREATED IN ITALY UNDER THE NAMED PATIENT PROGRAM – ZANOS STUDY
The primary analysis of MAGNOLIA, which led to drug approval, demonstrated that the next-generation BTK inhibitor zanubrutinib provided a high overall response rate (ORR) in patients with relapsed/refractory marginal zone lymphoma (R/R MZL), with a favorable safety/tolerability profile…
-
Artikel Jurnal
DP119 | REAL-WORLD SAFETY AND EFFICACY OF CAR-T CELLS THERAPIES FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA: THE CAR-T ITALIAN OBSERVATIONAL STUDY
The treatment of RRMM witnessed the introduction of chimeric antigen receptor T-cell (CAR-T) therapies targeting the B Cell Maturation Antigen (BCMA). However, their efficacy and safety profile stemmed from controlled clinical trials, whose patients’ (pts) characteristics may not adequately mirror…
-
Artikel Jurnal
C074 | CRS-PSS TO IDENTIFY MANTLE CELL LYMPHOMA PATIENTS AT HIGHER RISK FOR TOXICITIES BURDEN OF CAR T CELLS: A VALIDATION ANALYSIS FROM THE ITALIAN CAR-T SIE STUDY
Chimeric antigen receptor T-cells have revolutionized treatment of B-cell lymphomas, including mantle cell lymphoma (MCL), with the limit of toxicities as cytokine release syndrome (CRS) and neurotoxicity (ICANS). Two prognostic scoring systems (PSS), CRS-PSS and ICANS-PSS, were developed to…
-
Artikel Jurnal
C011 | CAR-T CELLS SPECIFIC TOXICITIES AS MAJOR DETERMINANTS OF NON-RELAPSE MORTALITY: AN ANALYSIS FROM THE ITALIAN CART-SIE STUDY
Chimeric antigen receptor (CAR)-T cell therapy has revolutionized outcomes of patients (pts) with relapsed/refractory lymphomas, yet non-relapse mortality (NRM) has emerged as a notable concern, with ECOG, older age and infections identified as major drivers in real-life studies. Within the…
-
Artikel Jurnal
DP120 | A NATIONWIDE ITALIAN SURVEY ON TANDEM AUTOLOGOUS STEM-CELL TRANSPLANTATION FOR NEWLY DIAGNOSED MULTIPLE MYELOMA TREATED WITH DARATUMUMAB-BORTEZOMIB-THALIDOMIDE-DEXAMETHASONE INDUCTION
Quadruplet induction with D-VTd followed by single ASCT is the current standard treatment for NDMM in European Countries. However, in the latest EHA guidelines tandem ASCT is still recommended as an option for high-risk (HR) patients (pts), based on previous studies suggesting a survival benefit in…
-
Artikel Jurnal
C014 | EFFICACY AND SAFETY OF IBRUTINIB AS SECOND-LINE TREATMENT IN RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA: INTERIM ANALYSIS OF THE OLIMPUS STUDY
Introduction: Mantle cell lymphoma (MCL) is an incurable disease characterized by an aggressive clinical course. Ibrutinib has been approved for relapsed/refractory (R/R) MCL and rapidly became standard therapy in the second-line setting. Several studies have reported results with ibrutinib in R/R…